Aerovate Therapeutics Inc (AVTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AVTE | AZN | AMGN | GILD | VRTX |
| Company | Aerovate Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 93.10 | 183.40 | 348.00 | 125.56 | 471.38 |
| High | 96.95 | 184.47 | 353.19 | 127.27 | 477.51 |
| Low | 92.04 | 182.68 | 346.00 | 125.00 | 469.93 |
| Latest | 93.80 | 182.35 | 351.00 | 125.38 | 476.50 |
| Change | unch | +1.33 | +3.99 | +0.33 | +8.08 |
| % Change | unch | +0.73% | +1.15% | +0.26% | +1.72% |
| Volume | 29,368 | 492,809 | 326,416 | 1,303,689 | 221,569 |
| 20-Day Average Volume | 643,590 | 1,888,881 | 3,014,660 | 8,800,653 | 1,364,940 |
| Previous Close | 93.80 | 181.02 | 347.01 | 125.05 | 468.42 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.62 | 180.62 | 342.94 | 127.68 | 447.63 |
| 20-Day Raw Stochastic | 56.10% | 64.82% | 82.11% | 29.32% | 96.83% |
| 20-Day Relative Strength | 58.16 | 50.01 | 55.48 | 44.30 | 63.11 |
| Weighted Alpha | +50.21 | +22.98 | +23.57 | +8.30 | +12.48 |
| Today's Opinion | 88% Buy | 40% Sell | 56% Buy | 72% Sell | 40% Buy |
| Previous Opinion | 88% Buy | 56% Sell | 40% Buy | 72% Sell | 40% Buy |
| Last Month's Opinion | 24% Sell | 8% Sell | 8% Sell | 8% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.25% since 04/21/25 | +2.64% since 06/16/26 | +1.19% since 06/16/26 | -0.95% since 06/16/26 | +4.97% since 06/16/26 |
| Low | 2.57 on 04/25/25 | 173.65 on 06/18/26 | 334.05 on 06/18/26 | 122.43 on 06/18/26 | 447.54 on 06/17/26 |
| High | 2.86 on 04/22/25 | 184.39 on 06/24/26 | 353.19 on 06/24/26 | 128.20 on 06/17/26 | 477.51 on 06/24/26 |
| 1-Month | |||||
| %Chg | +5.93% since 03/28/25 | -1.93% since 05/22/26 | +3.74% since 05/22/26 | -6.20% since 05/22/26 | +9.47% since 05/22/26 |
| Low | 2.45 on 04/04/25 | 173.65 on 06/18/26 | 322.30 on 06/02/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 2.86 on 04/22/25 | 188.72 on 05/27/26 | 358.46 on 06/11/26 | 137.20 on 05/29/26 | 477.51 on 06/24/26 |
| 3-Month | |||||
| %Chg | +8.94% since 01/28/25 | -1.27% since 03/24/26 | +1.02% since 03/24/26 | -8.75% since 03/24/26 | +6.03% since 03/24/26 |
| Low | 2.24 on 03/18/25 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 2.86 on 04/22/25 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 477.51 on 06/24/26 |
| 6-Month | |||||
| %Chg | +22.94% since 10/28/24 | -0.80% since 12/24/25 | +5.40% since 12/24/25 | +0.28% since 12/24/25 | +2.74% since 12/24/25 |
| Low | 2.17 on 10/29/24 | 173.65 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 3.00 on 10/31/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 77,680 | 280,745,344 | 187,284,080 | 155,258,336 | 118,887,344 |
| Shares Outstanding, K | 28,985 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -69,630,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -2,520,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 0.95 | 0.25 | 0.42 | 0.31 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 03/27/25 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 08/11/25 | 08/04/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.05 | 15.60 | 14.92 | 27.75 |